Company Profile

BioForce Nanosciences Inc (AKA: Bioforce Laboratory~Bioforce Nanosciences Inc)
Profile last edited on: 1/17/2019      CAGE: 1WCS3      UEI: Z9SCJJE5VJK6

Business Identifier: Ultra-miniaturized nanoarray technologies for solid-phase, high-throughput biomolecular analysis
Year Founded
1994
First Award
1995
Latest Award
2007
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

609 East Lincoln Way Suite 609
Ames, IA 50010
   (515) 233-8333
   info@bioforcenano.com
   www.bioforcenano.com
Location: Multiple
Congr. District: 04
County: Story

Public Profile

BioForce Nanosciences, Inc., is a subsiduary of BioForce Nanosciences Holdings, Inc., that was traded on OTC. The firm works on integrating biological and mechanical systems at the ultramicro and nano scales for the biomedical and life sciences industries. Product includes The Nano eNabler System, which deposit biological materials, such as proteins or DNA, onto solid surfaces, such as silicon or glass, in extremely small quantities. This product is capable of depositing these biological materials in ultramicroscopic to attoliter volumes in spots. The company's Nano eNabler System is used in the production of ultraminiaturized biological sensors, biologically active micro-environments, biomedical tests, and other ultraminiaturized devices. It also develops consumable printing and surface patterning tools to support the Nano eNabler system, which include surface patterning tools and silicon chips. In addition, the company markets a line of accessories for atomic force microscopes and scanning probe microscopes. It also develops ViriChip platform, an ultramicroscale biosensor platform for the detection and identification of microbial pathogens and viruses

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : BFNH.OB
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2007 2 NIH $400,000
Project Title: BioMarker Analysis from Single Cells using Nanobiosensor
2007 2 NIH $1,199,891
Project Title: Microfabricated Deposition Tools for Creating NanoArrays
2005 2 NIH $399,999
Project Title: Biomolecular Profilometer
2004 1 NIH $101,251
Project Title: Profiling Cancer using Reverse-Phase NanoArrays
2004 2 NIH $499,769
Project Title: Protein NanoArray for Cytokine Profiling in Mouse Models

Key People / Management

  Kerry M Frey -- President

  Eric R Henderson

  Curtis L Mosher -- VP, R&D

  Laurence Russ -- former President

Company News

There are no news available.